Global Longlife Hospital & Research (BOM:543520) COGS-to-Revenue : 2.05 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Global Longlife Hospital & Research COGS-to-Revenue?

Global Longlife Hospital & Research's Cost of Goods Sold for the six months ended in Mar. 2024 was ₹24.3 Mil. Its Revenue for the six months ended in Mar. 2024 was ₹11.8 Mil.

Global Longlife Hospital & Research's COGS to Revenue for the six months ended in Mar. 2024 was 2.05.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Global Longlife Hospital & Research's Gross Margin % for the six months ended in Mar. 2024 was -105.31%.

Global Longlife Hospital & Research COGS-to-Revenue Historical Data

The historical data trend for Global Longlife Hospital & Research's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Longlife Hospital & Research COGS-to-Revenue Chart

Global Longlife Hospital & Research Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.68

0.66

0.53

0.57

0.63

Global Longlife Hospital & Research Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial				0.57	0.54	0.61	0.49	2.05

Global Longlife Hospital & Research COGS-to-Revenue Calculation

Global Longlife Hospital & Research's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	84.648	/	135.145
	=	0.63

Global Longlife Hospital & Research's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	24.319	/	11.845
	=	2.05

Global Longlife Hospital & Research (BOM:543520) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Global Longlife Hospital & Research's Gross Margin % for the six months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	24.319 / 11.845
	=	-105.31 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Global Longlife Hospital & Research COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Global Longlife Hospital & Research's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Longlife Hospital & Research (BOM:543520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Longlife Hospital & Research Ltd (BOM:543520) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pakwan Cross Road, Near Sindhubhavan Road, Near Water Tank, Opposite Auda Garden, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.globalhospital.co.in

Global Longlife Hospital & Research Ltd provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services.

Global Longlife Hospital & Research (BOM:543520) Headlines

No Headlines